Willingness to take buprenorphine/naloxone among people who use opioids in Vancouver, Canada – Weicker SA, Hayashi K, Grant C, Milloy MJ, Wood E, Kerr T.

OBJECTIVES: Opioid agonist therapy is the cornerstone of treatment of opioid use disorder. In Canada, buprenorphine/naloxone has recently been adopted as the first line agonist therapy given its comparable effectiveness to methadone and superior safety pro… (Source: SafetyLit)